Cell and Gene Therapy News

Discovery of CTLA-4 in dendritic cells opens new possibilities to fight cancerApr 4, 2016
Baylor College of Medicine researchers have discovered that CTLA-4 is produced and secreted by dendritic cells, which are the ‘generals’ of the T cells in the battle against cancer.
Heslop named director of Center for Cell and Gene TherapyApr 1, 2016
The Baylor College of Medicine Board of Trustees named Dr. Helen Heslop as director of the Center for Cell and Gene Therapy.
Grants support Baylor researchers’ work on immunotherapy for leukemiaOct 2, 2015
Two Baylor researchers have received Translational Research Grants for projects that use immunotherapy approaches to treat leukemia.
Safety switch preserves beneficial effects of cell therapyMay 14, 2015
Researchers have found that a single dose of an otherwise harmless drug can safely control the severe and often lethal side effects associated with haploidentical stem cell transplantation.
Novel cell therapy from 'naïve' cells recognizes, attacks high-risk viruses for first time in cord blood transplant patientsApr 29, 2015
Virus-specific cell therapy used in cord blood transplant patients successfully prevented 3 of the most problematic post-transplant viruses affecting this group of patients – cytomegalovirus, Epstein-Barr virus, and adenovirus.
Grant supports research on potential immunotherapy treatment for neuroblastomaDec 30, 2014

Dr. Leonid Metelitsa, named among inaugural recipients of the Bio-therapeutics Impact Award from Alex’s Lemonade Stand.

Developmental transcription factors oversee glioma sub-typesOct 6, 2014
Researchers find transcription factors NFIA, Sox10 play important roles in the development of different subtypes of deadly brain tumors.
Dr. Malcolm Brenner receives prestigious lifetime achievement honor from Human Gene Therapy journal Aug 5, 2014
Renowned cell and gene therapy clinician-scientist Dr. Malcolm Brenner has received the prestigious Pioneer Award from the journal Human Gene Therapy.
New study advances safety, efficacy profile of virus-specific T cells for post-transplant recipientsJun 25, 2014
Using specialized, virus-specific immune cells called T cells, researchers have identified a novel safe, effective and rapid approach to protect from the threat of multiple severe infections at once.
Dr. Malcolm Brenner recipient of Pediatric Blood and Marrow Transplant Consortium Lifetime Achievement AwardFeb 13, 2014
Renowned cell and gene therapy researcher Dr. Malcolm Brenner has been named a recipient of the Pediatric Blood and Marrow Transplant Consortium’s Lifetime Achievement Award.